C
IONS icon

Covestor’s Ionis Pharmaceuticals IONS Stock Holding History

Covestor’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
196
+14
+8% +$1.05K 0.01% 1272
2026
Q1 		$14K Sell
182
-91
-33% -$7.18K 0.01% 1259
2025
Q4 		$22K Buy
273
+27
+11% +$2.03K 0.01% 1251
2025
Q3 		$16K Sell
246
-59
-19% -$2.88K 0.01% 1365
2025
Q2 		$12K Buy
305
+7
+2% +$229 0.01% 1474
2025
Q1 		$9K Buy
298
+52
+21% +$1.7K 0.01% 1559
2024
Q4 		$9K Sell
246
-4
-2% -$150 0.01% 1595
2024
Q3 		$10K Buy
250
+7
+3% +$326 0.01% 1562
2024
Q2 		$12K Buy
243
+1
+0.4% +$41 0.01% 1412
2024
Q1 		$11K Sell
242
-1
-0.4% -$48 0.01% 1514
2023
Q4 		$12K Hold
243
– – 0.01% 1428
2023
Q3 		$11K Sell
243
-3
-1% -$124 0.01% 1379
2023
Q2 		$10K Sell
246
-2
-0.8% -$77 0.01% 1435
2023
Q1 		$9K Buy
248
+2
+0.8% +$75 0.01% 1366
2022
Q4 		$9K Sell
246
-11
-4% -$463 0.01% 1370
2022
Q3 		$11K Sell
257
-109
-30% -$4.59K 0.01% 1225
2022
Q2 		$14K Sell
366
-11
-3% -$415 0.01% 1087
2022
Q1 		$14K Buy
377
+345
+1,078% +$11.3K 0.01% 1188
2021
Q4 		$1K Buy
+32
New +$1.01K ﹤0.01% 1789

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Covestor's IONS Position: Q2 2026 in Review

Covestor increased its Ionis Pharmaceuticals (IONS) stake by 7.7% in Q2 2026, buying an estimated $1.05K and bringing the position to 196 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #1272.

Covestor first reported a position in IONS in Q4 2021 and has held it in 19 quarters since. The position peaked at $22K in Q4 2025. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Covestor held 196 shares of Ionis Pharmaceuticals worth $16K as of Q2 2026.
  • Covestor bought 14 Ionis Pharmaceuticals shares in Q2 2026, an estimated $1.05K.
  • Ionis Pharmaceuticals made up 0.01% of Covestor's portfolio in Q2 2026, its #1272 holding.
  • Covestor first reported a position in Ionis Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Ionis Pharmaceuticals position peaked at $22K in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.